NFATC2IP and type 2 diabetes mellitus: Results were consistent across tissues, with increased expression of ATP2A1, NFATC2IP, SPNS1, and TUFM increasing T2D risk, and increased expression of SH2B1 and ATXN2L decreasing risk for T2D, even if for the latter the effect was only found in whole blood.